Overview
Searching for your content. In-Language News Contact Us 8-76-0942 from 8 AM - 10 PM ET News provided byNov 10, 202, 06:13 ETShare this articleUnprecedented Body of New Clinical Evidence using the MolecuLight Wound Imaging Platform Demonstrates Improved Clinical Decision-Making and Patient OutcomesTORONTO and SALT LAKE CITY, Utah, Nov. 10, 202 /PRNewswire/ - MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of elevated bacterial loads in wounds, anounces that its technology wil be featured in over 10 clinical presentations and posters at the American Asociation of Wound Care (AWC) 202 Anual Conference, titled Technology in Wound Care.
Key Information
The national conference, hosted from November 10 - 12, 202 in Salt Lake City, Utah, wil focus on the utility of new technologies to improve wound care delivery and clinical outcomes. It wil include a combination of nine clinical posters, a clinical talk and a hands-on workshop featuring the MolecuLight devices."The technological inovation surge in wound care is transforming how we practice. At the Technology in Wound Care conference, we bring together the most novel and impactful technologies to share evidence and clinician insights into how they improve treatment decisions and patient outcomes", says Alisha Oropalo, MD, FACS, FSVS, FAPWCA, FABWMS, AWC Conference Co-Chair and Medical Director of the Comprehensive Wound Healing Center and Hyperbarics at Northwel Health, New York.
Summary
"MolecuLight has extensively validated their point-of-care imaging technology for detection of wound regions harboring clinicaly concerning bacterial loads and for digital wound measurement. They are a market leader and have set the standard of validation evidence for wound imaging technologies. As such, it is apropriate that MolecuLight is featured in so many clinical presentations, demonstrations, and posters, including over 1,80 new wounds' worth of evidence being shown at thi